According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012. Cardiovascular disease can be prevented by addressing behavioral risks such as obesity, cigarette smoking, and an unhealthy diet. CRT device is an implantable medical device that are used to resynchronize the contractions of the heart?s ventricles by sending tiny electrical impulses to the heart muscle, to pump the blood more efficiently. One of the various factors that back the market growth of cardiac resynchronization therapy devices market is the expanding pool of aging and geriatric patients worldwide. That segment of the human population is more vulnerable to chronic illness and is, as such, expected to generate the immense need for these resynchronization therapy gadgets so as to facilitate and accelerate sound heart activity. Other than cardiac arrest, there are some other medical conditions like atrial fibrillation, congenital heart disease, and arrhythmias?which also require the implementation and usage of these cardiac resynchronization therapy devices. Growing prevalence of various cardiovascular diseases like cardiac arrest, sick sinus syndrome, and bradycardia are also bolstering the growth of market. To diminish the rate of mortality arising out of cardiovascular illness, many hospitals have already initiated the use of CRT-Ps for managing the failures of heart. Furthermore, many doctors are increasing the usage of surgeries that are minimally invasive (MI) for various CRT-Ps implantation. These procedures are considered safe, diminish the blood transfusion requirement. It also decreases chances of infections and reduces stay at the hospital. This eventually accelerates the recovering and process thereby leading to much improved clinical outcome. This change in inclination towards minimally invasive procedures for the purpose of CRT-Ps implantation is poised to trigger the sales of the cardiac resynchronization therapy devices in the years to come. The North American region is expected to contribute the highest revenue over the forecast period due to rising approvals by the U.S. FDA for new products and increasing growth of geriatric population suffering from cardiac dysfunction. As of 2016, it held more 36.0% of the global market share. Europe also held a substantial share and is predicted to witness lucrative growth with CAGR of more than 7.4% over the next nine years. Higher stringency being implemented by the healthcare agencies toward R&D, safety guideline follow-up, and product approvals are expected to drive the growth. The global Cardiac Resynchronization Therapy (CRT) Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Cardiac Resynchronization Therapy (CRT) Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Resynchronization Therapy (CRT) Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cardiac Resynchronization Therapy (CRT) Devices in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Cardiac Resynchronization Therapy (CRT) Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. The following manufacturers are covered: Boston Scientific Medtronic St. Jude Medical Biotronik Cook Medical Sorin Group ... Segment by Regions North America Europe China Japan Southeast Asia India Segment by Type CRT-Pacemakers CRT-Defibrillators Segment by Application Healthcare Industry Cardiovascular industry
Table of Contents Executive Summary 1 Industry Overview of Cardiac Resynchronization Therapy (CRT) Devices 1.1 Definition of Cardiac Resynchronization Therapy (CRT) Devices 1.2 Cardiac Resynchronization Therapy (CRT) Devices Segment by Type 1.2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Production Growth Rate Comparison by Types (2014-2025) 1.2.2 CRT-P
